Objects
Larance, Briony, Bruno, Raimondo, Mattick, Richard P., Lintzeris, Nicholas, Degenhardt, Louise, Black, Emma, Brown, Amanda, Nielsen, Suzanne, Dunlop, Adrian, Holland, Rohan, Cohen, Milton. Elsevier; 2016. Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: the Opioid-Related Behaviours In Treatment (ORBIT) scale.
Nielsen, Suzanne, Picco, Louisa, Farrell, Michael, Lintzeris, Nicholas, Le Foll, Bernard, Murnion, Bridin, Winters, Bryony, Matheson, Justin, Graham, Myfanwy, Campbell, Gabrielle, Parvaresh, Laila, Khor, Kok-Eng, Betz-Stablein, Brigid. Nature Publishing Group; 2022. Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies.
Farrell, Michael, Shahbazi, Jeyran, Byrne, Marianne, Grebely, Jason, Lintzeris, Nicholas, Chambers, Mark, Larance, Briony, Ali, Robert, Nielsen, Suzanne, Dunlop, Adrian, Dore, Gregory J., McDonough, Michael, Montebello, Mark, Nicholas, Thomas, Weiss, Rob, Rodgers, Craig, Cook, Jon, Degenhardt, Louisa. Elsevier; 2022. Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence.
Nielsen, Suzanne, Bruno, Raimondo, Murnion, Bridin, Dunlop, Adrian, Degenhardt, Louisa, Demirkol, Apo, Muhleisen, Peter, Lintzeris, Nicholas. Wiley-Blackwell; 2016. Treating codeine dependence with buprenorphine: dose requirements and induction outcomes from a retrospective case series in New South Wales, Australia.
Farrell, Michael, Shahbazi, Jeyran, Nielsen, Suzanne, Dunlop, Adrian, Dore, Gregory J., McDonough, Michael, Montebello, Mark, Weiss, Rob, Rodgers, Craig, Cook, Jon, Degenhardt, Louisa, Chambers, Mark, Byrne, Marianne, Gholami, Jaleh, Zahra, Emma, Grebely, Jason, Lintzeris, Nicholas, Larance, Briony, Ali, Robert. Elsevier; 2024. 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial.
Langford, Aili V., Bero, Lisa, Lin, Chung-Wei Christine, Blyth, Fiona M., Doctor, Jason N., Holliday, Simon, Jeon, Yun-Hee, Moullin, Joanna C., Murnion, Bridin, Nielsen, Suzanne, Penm, Jonathan, Reeve, Emily, Reid, Sharon, Wale, Janet, Osman, Rawa, Gnjidic, Danijela, Schneider, Carl R.. Elsevier; 2024. Context matters: using an Evidence to Decision (EtD) framework to develop and encourage uptake of opioid deprescribing guideline recommendations at the point-of-care.
Murnion, Bridin Patricia, Rivas, Consuelo, Demirkol, Apo, Hayes, Vicky, Lintzeris, Nicholas, Nielsen, Suzanne. Oxford University Press; 2020. Acute experimental pain responses in methadone- and buprenorphine/naloxone-maintained patients administered additional opioid or gabapentin: a double-blind crossover pilot study.
Nielsen, Suzanne, Lintzeris, Nicholas, Dunlop, Adrian, Demirkol, Apo, Silsbury, Catherine, Phung, Nghi, Houseman, Jennie, Larance, Briony, Murnion, Bridin, Degenhardt, Louisa, Bruno, Raimondo, Haber, Paul, Johnson, Jennifer, Hardy, Mark, Ling, Stephen, Saddler, Craig. Wiley-Blackwell; 2018. Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence.
Langford, Aili V., Lin, Christine C. W., Osman, Rawa, Penm, Jonathan, Reeve, Emily, Reid, Sharon, Wale, Janet, Schneider, Carl R., Gnjidic, Danijela, Bero, Lisa, Blyth, Fiona M., Doctor, Jason, Holliday, Simon, Jeon, Yun-Hee, Moullin, Joanna, Murnion, Bridin, Nielsen, Suzanne. John Wiley & Sons; 2023. Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations.
Settumba, Stella, Shahbazi, Jeyran, Blazey, Alison, Weiss, Robert, Dunlop, Adrian, McDonough, Michael, Cook, Jon, Farrell, Michael, Byrne, Marianne, Degenhardt, Louisa, Grebely, Jason, Larance, Briony, Nielsen, Suzanne, Lintzeris, Nicholas, Ali, Robert, Rodgers, Craig. Wiley-Blackwell; 2025. Provider costs of treating opioid dependence with extended-release buprenorphine in Australia.